Position:
Founder at Anatara Medicine, Chairman, Board of Directors at Institute Rare & Neglected Disease Drug Discovery (iRND3), Board of Directors at Pulmonary Vascular Research Institute, Clinical Professor of Medicine at University of California, San Francisco
Location:
San Francisco, California
Work:
Anatara Medicine
- 1700 California Street; Suite 520, San Francisco, CA 94109 since 2010
-
Founder
Institute Rare & Neglected Disease Drug Discovery (iRND3)
since 2010
-
Chairman, Board of Directors
Pulmonary Vascular Research Institute
since Jan 2007
-
Board of Directors
University of California, San Francisco
since Jan 1999
-
Clinical Professor of Medicine
Medicines360
2009 - 2010
-
Senior Advisor
Institute for OneWorld Health
2000 - 2009
-
Co-Founder, Chief Operating and Medical Officer
Ischemia Research & Education Foundation (IREF)
Jan 1995 - May 1999
-
Vice President, Head of Research
The Johns Hopkins Medical Institution
Jul 1986 - Jan 1995
-
Asst & Associate Professor of Medicine & Molecular Microbiology and Immunology
Johns Hopkins Hospital
Jul 1983 - Jul 1986
-
Cardiology Fellow
Greenwich Hospital, Yale University School of Medicine
Jul 1980 - Jul 1983
-
Resident & Chief Resident, Internal Medicine
Albert Einstein College of Medicine
Jul 1977 - Jul 1980
-
Resident & Chief Resident, Anatomic Pathology
Education:
Albert Einstein College of Medicine of Yeshiva University 1974 - 1977
MD, Medicine
City University of New York-Brooklyn College 1970 - 1974
BA, Mathematics, Economics
Skills:
Pharmaceuticals, Clinical, Immunology, Prevention, Health, Clinical Trials, Integrative Thinking
Interests:
non-profit sustainability strategy, new technology assessment, business development, medical-legal consultation
Honor & Awards:
Clinton Foundation Global Health Initiative, Access to Cures Award, 2007
Bay Bio, Outstanding Pharmaceutical Product of the Year, 2008